Redox signaling and the emerging therapeutic potential of thiol antioxidants

Biochemical Pharmacology

Volumn 55, Issue 11, 1998, Pages 1747-1758

  Sen, Chandan K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Free radical; Gene expression; Reactive oxygen species; Transcription

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; DOXORUBICIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOREDUCTASE; PROTEIN C FOS; PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; RYANODINE RECEPTOR; THIOCTIC ACID; THIOL GROUP; THIOREDOXIN; TRANSFORMING GROWTH FACTOR BETA1; ZINC FINGER PROTEIN;

CANCER; ELECTRON TRANSPORT; ENZYME ACTIVITY; GENE EXPRESSION; ONCOGENE C JUN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0032100603     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00672-2     Document Type: Article

References (134)

1. Muller J.M., Rupec R.A., Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 11:1997;301-312.
2. 2+ in oxidant-induced NF-κB activation. FEBS Lett. 385:1996;58-62.
3. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
4. Müller J.M., Cahill M.A., Rupec R.A., Baeuerle P.A., Nordheim A. Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1. Eur J Biochem. 244:1997;45-52.
5. Huang R.P., Adamson E.D. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor Evidence for modulation by a redox mechanism. DNA Cell Biol. 12:1993;265-273.
6. Nose K., Ohba M. Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide. Biochem J. 316:1996;381-383.
7. Kagoshima H., Akamatsu Y., Ito Y., Shigesada K. Functional dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J Biol Chem. 271:1996;33074-33082.
8. Akamatsu Y., Ohno T., Hirota K., Kagoshima H., Yodoi J., Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J Biol Chem. 272:1997;14497-14500.
9. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol. 16:1996;1035-1046.
10. Beiqing L., Chen M., Whisler R.L. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. J Immunol. 157:1996;160-169.
11. Nakshatri H., Bhat-Nakshatri P., Currie R.A. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Chem. 271:1996;28784-28791.
12. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem. 271:1996;32253-32259.
13. Liu H., Lightfoot R., Stevens J.L. Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem. 271:1996;4805-4812.
14. Ireland R.C., Li S.Y., Dougherty J.J. The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch Biochem Biophys. 319:1995;470-480.
15. Martin M.E., Chinenov Y., Yu M., Schmidt T.K., Yang X-Y. Redox regulation of GA-binding protein-α DNA binding activity. J Biol Chem. 271:1996;25617-25623.
16. Kambe F., Nomura Y., Okamoto T., Seo H. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol. 10:1996;801-812.
17. Chivers P.T., Prehoda K.E., Raines R.T. The CXXC motif A rheostat in the active site . Biochemistry. 36:1997;4061-4066.
18. Taniguchi Y., Taniguchi-Ueda Y., Mori K., Yodoi J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 24:1996;2746-2752.
19. Jornot L., Junod A.F. Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism. Biochem J. 326:1997;117-123.
20. Warner B.B., Stuart L., Gebb S., Wispe J.R. Redox regulation of manganese superoxide dismutase. Am J Physiol. 271:1996;L150-L158.
21. Bindoli A., Callegaro M.T., Barzon E., Benetti M., Rigobello M.P. Influence of the redox state of pyridine nucleotides on mitochondrial sulfhydryl groups and permeability transition. Arch Biochem Biophys. 342:1997;22-28.
22. Nakamura J., Bannai S. Glutathione alters the mode of calcium-mediated regulation of adenylyl cyclase in membranes from mouse brain. Biochim Biophys Acta. 1339:1997;239-246.
23. 2+ release mechanism. J Biol Chem. 272:1997;7069-7077.
24. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 108:1996;277-293.
25. - channels. Am J Physiol. 272:1997;C324-C332.
26. Sen C.K., Kolosova I., Hanninen O., Orlov S.N. Inward potassium transport systems in skeletal muscle derived cells are highly sensitive to oxidant exposure. Free Radic Biol Med. 18:1995;795-800.
27. Schenk H., Vogt M., Droge W., Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J Immunol. 156:1996;765-771.
28. Zhang J.G., Matthews J.M., Ward L.D., Simpson R.J. Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state. Biochemistry. 36:1997;2380-2389.
29. Barcellos-Hoff M.H., Dix T.A. Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol. 10:1996;1077-1083.
30. (waf1/cip1) expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem. 245:1997;730-737.
31. (ras) interaction. J Biol Chem. 272:1997;4323-4326.
32. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts [see comments]. Science. 275:1997;1649-1652.
33. 2-terminal kinase) is a target for antioxidants in T lymphocytes. J Biol Chem. 271:1996;26335-26340.
34. Laderoute K.R., Webster K.A. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res. 80:1997;336-344.
35. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem. 271:1996;16586-16590.
36. Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 272:1997;15642-15649.
37. Goldstone S.D., Hunt N.H. Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta. 1355:1997;353-360.
38. Meili R., Ballmer-Hofer K. Activation-independent nuclear translocation of mitogen activated protein kinase ERK1 mediated by thiol-modifying chemicals. FEBS Lett. 394:1996;34-38.
39. Wilmer W.A., Tan L.C., Dickerson J.A., Danne M., Rovin B.H. Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J Biol Chem. 272:1997;10877-10881.
40. Yamauchi A., Bloom E.T. Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood. 89:1997;4092-4099.
41. lck in T cells. Oncogene. 8:1993;3133-3139.
42. Zipser Y., Piade A., Kosower N.S. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett. 406:1997;126-130.
43. Rouault T.A., Klausner R.D. Iron-sulfur clusters as biosensors of oxidants and iron [erratum appears in Trends Biochem Sci 21: 246, 1996] [see comments]. Trends Biochem Sci. 21:1996;174-177.
44. Pantopoulos K., Mueller S., Atzberger A., Ansorge W., Stremmel W., Hentze M.W. Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem. 272:1997;9802-9808.
45. Bouton C., Hirling H., Drapier J.C. Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem. 272:1997;19969-19975.
46. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., Tanaka H. Thioredoxin A redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system . J Clin Invest. 98:1996;2469-2477.
47. Zottola R.J., Cloherty E.K., Coderre P.E., Hansen A., Hebert D.N., Carruthers A. Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry. 34:1995;9734-9747.
48. Aizenman E., Hartnett K.A., Reynolds I.J. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron. 5:1990;841-846.
49. Bernard C.L., Hirsch J.C., Khazipov R., Ben-Ari Y., Gozlan H. Redox modulation of synaptic responses and plasticity in rat CA1 hippocampal neurons. Exp Brain Res. 113:1997;343-352.
50. Quesada O., Hirsch J., Ben-Ari Y., Bernard C. Redox sites of NMDA receptors can modulate epileptiform activity in hippocampal slices from kainic acid-treated rats. Neurosci Lett. 212:1996;171-174.
51. Sinor J.D., Boeckman F.A., Aizenman E. Intrinsic redox properties of N-methyl-D-aspartate receptor can determine the developmental expression of excitotoxicity in rat cortical neurons in vitro. Brain Res. 747:1997;297-303.
52. Lautier D., Luscher P., Tyrrell R.M. Endogenous glutathione levels modulate both constitutive and UVA radiation/hydrogen peroxide inducible expression of the human heme oxygenase gene. Carcinogenesis. 13:1992;227-232.
53. McDuffee A.T., Senisterra G., Huntley S., Lepock J.R., Sekhar K.R., Meredith M.J., Borrelli M.J., Morrow J.D., Freeman M.L. Proteins containing non-native disulfide bonds generated by oxidative stress can act as signals for the induction of the heat shock response. J Cell Physiol. 171:1997;143-151.
54. Gardner P.R. Superoxide-driven aconitase Fe-S center cycling. Biosci Rep. 17:1997;33-42.
55. Abate C., Patel L., Rauscher F.J. III, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
56. Okuno H., Akahori A., Sato H., Xanthoudakis S., Curran T., Iba H. Escape from redox regulation enhances the transforming activity of Fos. Oncogene. 8:1993;695-701.
57. Kumar S., Rabson A.B., Gélinas C. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol Cell Biol. 12:1992;3094-3106.
58. Bressler P., Brown K., Timmer W., Bours V., Siebenlist U., Fauci A.S. Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant p50 mutants. J Virol. 67:1993;288-293.
59. Toledano M.B., Ghosh D., Trinh F., Leonard W.J. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65. Mol Cell Biol. 13:1993;852-860.
60. Hayashi T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor κ B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem. 268:1993;11380-11388.
61. Matthews J.R., Wakasugi N., Virelizier J-L, Yodoi J., Hay R.T. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821-3830.
62. Chivers P.T., Laboissiere M.C., Raines R.T. The CXXC motif Imperatives for the formation of native disulfide bonds in the cell . EMBO J. 15:1996;2659-2667.
63. Leibrecht I., Kessler D. A novel L-cysteine/cystine C-S-lyase directing [2Fe-2S] cluster formation of Synechocystis ferredoxin. J Biol Chem. 272:1997;10442-10447.
64. Knebel A., Rahmsdorf H.J., Ullrich A., Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Embo J. 15:1996;5314-5325.
65. Hansson T., Nordlund P., Aqvist J. Energetics of nucleophile activation in a protein tyrosine phosphatase. J Mol Biol. 265:1997;118-127.
66. Zhang Z-Y, Wu L. The single sulfur to oxygen substitution in the active site nucleophile of the Yersinia protein-tyrosine phosphatase leads to substantial structural and functional perturbations. Biochemistry. 36:1997;1362-1369.
67. 2 and vanadate in vitro. Biochem Biophys Res Commun. 188:1992;773-779.
68. 2 and vanadate administration into rat livers . Mol Cell Endocrinol. 97:1993;9-17.
69. 2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic Biol Med. 16:1994;399-403.
70. Donoso P., Rodriguez P., Marambio P. Rapid kinetic studies of SH oxidation-induced calcium release from sarcoplasmic reticulum vesicles. Arch Biochem Biophys. 341:1997;295-299.
71. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med. 22:1997;269-285.
72. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., Roth S., Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8:1994;1131-1138.
73. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol. 15:1997;351-369.
74. Hill K.E., McCollum G.W., Boeglin M.E., Burk R.F. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun. 234:1997;293-295.
75. Arscott L.D., Gromer S., Schirmer R.H., Becker K., Williams C.H. Jr. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA. 94:1997;3621-3626.
76. Ren X., Bjornstedt M., Shen B., Ericson M.L., Holmgren A. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry. 32:1993;9701-9708.
77. Chae H.Z., Rhee S.G. A thiol-specific antioxidant and sequence homology to various proteins of unknown function. Biofactors. 4:1994;177-180.
78. Yim M.B., Chae H.Z., Rhee S.G., Chock P.B., Stadtman E.R. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J Biol Chem. 269:1994;1621-1626.
79. Netto L.E.S., Chae H.Z., Kang S.W., Rhee S.G., Stadtman E.R. Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J Biol Chem. 271:1996;15315-15321.
80. Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem. 272:1997;2936-2941.
81. Thelander L., Reichard P. Reduction of ribonucleotides. Annu Rev Biochem. 48:1979;133-158.
82. Lundstrom J., Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem. 265:1990;9114-9120.
83. Grippo J.F., Holmgren A., Pratt W.B. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem. 260:1985;93-97.
84. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H., Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction [erratum appears in EMBO J 13: 2244, 1994]. EMBO J. 8:1989;757-764.
85. Li W., Churchich J.E. Activation of partially folded mitochondrial malate dehydrogenase by thioredoxin. Eur J Biochem. 246:1997;127-132.
86. Cromlish J.A., Roeder R.G. Human transcription factor IIIC (TFIIIC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding. J Biol Chem. 264:1989;18100-18109.
87. Bannister A.J., Cook A., Kouzarides T. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene. 6:1991;1243-1250.
88. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA. 94:1997;3633-3638.
89. Tanaka T., Nishiyama Y., Okada K., Hirota K., Matsui M., Yodoi J., Hiai H., Toyokuni S. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney Independence of tubular necrosis and sulfhydryl depletion. Lab Invest. 77:1997;145-155.
90. Masutani H., Hirota K., Sasada T., Ueda-Taniguchi Y., Taniguchi Y., Sono H., Yodoi J. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol Lett. 54:1996;67-71.
91. Ericson M.L., Horling J., Wendel-Hansen V., Holmgren A., Rosen A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 11:1992;201-207.
92. Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem. 267:1992;24161-24164.
93. Rubartelli A., Bonifaci N., Sitia R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55:1995;675-680.
94. Wakasugi N., Tagaya Y., Wakasugi H., Mitsui A., Maeda M., Yodoi J., Tursz T. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA. 87:1990;8282-8286.
95. Oblong J.E., Berggren M., Gasdaska P.Y., Powis G. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J Biol Chem. 269:1994;11714-11720.
96. Nakamura H., Masutani H., Tagaya Y., Yamauchi A., Inamoto T., Nanbu Y., Fujii S., Ozawa K., Yodoi J. Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer. 69:1992;2091-2097.
97. Gasdaska J.R., Berggren M., Powis G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ. 6:1995;1643-1650.
98. Biguet C., Wakasugi N., Mishal Z., Holmgren A., Chouaib S., Tursz T., Wakasugi H. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem. 269:1994;28865-28870.
99. Clarke F.M., Orozco C., Perkins A.V., Cock I., Tonissen K.F., Robins A.J., Wells J.R. Identification of molecules involved in the 'early pregnancy factor' phenomenon. J Reprod Fertil. 93:1991;525-539.
100. Newman G.W., Balcewicz-Sablinska M.K., Guarnaccia J.R., Remold H.G., Silberstein D.S. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med. 180:1994;359-363.
101. 2 upon thioredoxin-enriched lens epithelial cells. J Biol Chem. 263:1988;4984-4990.
102. Schallreuter K.U., Wood J.M. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun. 136:1986;630-637.
103. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide [erratum appears in Immunol Lett 42: 213, 1994]. Immunol Lett. 42:1994;75-80.
104. May J.M., Mendiratta S., Hill K.E., Burk R.F. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem. 272:1997;22607-22610.
105. Sen C.K., Hanninen O. Physiological antioxidants. Sen C.K., Packer L., Hanninen O. Exercise and Oxygen Toxicity. 1994;89-126 Elsevier Science Publishers B.V. Amsterdam.
106. Iwata S., Hori T., Sato N., Hirota K., Sasada T., Mitsui A., Hirakawa T., Yodoi J. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion Possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state . J Immunol. 158:1997;3108-3117.
107. Funasaka Y., Ichihashi M. The effect of ultraviolet B induced adult T cell leukemia-derived factor/thioredoxin (ADF/TRX) on survival and growth of human melanocytes. Pigment Cell Res. 10:1997;68-73.
108. Gasdaska J.R., Kirkpatrick D.L., Montfort W., Kuperus M., Hill S.R., Berggren M., Powis G. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation. Biochem Pharmacol. 52:1996;1741-1747.
109. Patel J.M., Zhang J., Block E.R. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols Role of thioredoxin in regulation of catalytic activity . Am J Respir Cell Mol Biol. 15:1996;410-419.
110. Nikitovic D., Holmgren A. S-Nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem. 271:1996;19180-19185.
111. Carelli S., Ceriotti A., Cabibbo A., Fassina G., Ruvo M., Sitia R. Cysteine and glutathione secretion in response to protein disulfide bond formation in the ER. Science. 277:1997;1681-1684.
112. Ginn-Pease M.E., Whisler R.L. Optimal NF-κB mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun. 226:1996;695-702.
113. Sen C.K., Khanna S., Reznick A.Z., Roy S., Packer L. Glutathione regulation of tumor necrosis factor-α-induced NF-κB activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun. 237:1997;645-649.
114. Esposito F., Agosti V., Morrone G., Morra F., Cuomo C., Russo T., Venuta S., Cimino F. Inhibition of the differentiation of human myeloid cell lines by redox changes induced through glutathione depletion. Biochem J. 301:1994;649-653.
115. Kuo M-L, Meng T-C, Lin J-K. Involvement of glutathione in induction of c-jun proto-oncogene by methylmethanesulfonate in NIH 3T3 cells. Carcinogenesis. 17:1996;815-820.
116. Rigacci S., Iantomasi T., Marraccini P., Berti A., Vincenzini M.T., Ramponi G. Evidence for glutathione involvement in platelet-derived growth-factor-mediated signal transduction. Biochem J. 324:1997;791-796.
117. Knoepfel L., Steinkuhler C., Carri M.T., Rotilio G. Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1. Biochem Biophys Res Commun. 201:1994;871-877.
118. 2+ store. Biochem J. 312:1995;485-489.
119. Wilhelm D., Bender K., Knebel A., Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol. 17:1997;4792-4800.
120. Oguro T., Hayashi M., Numazawa S., Asakawa K., Yoshida T. Heme oxygenase-1 gene expression by a glutathione depletor, phorone, mediated through AP-1 activation in rats. Biochem Biophys Res Commun. 221:1996;259-265.
121. Sen C.K. Nutritional biochemistry of cellular glutathione. J Nutr Biochem. 8:1997;660-672.
122. Sen C.K., Roy S., Han D., Packer L. Regulation of cellular thiols in human lymphocytes by α-lipoic acid A flow cytometric analysis . Free Radic Biol Med. 22:1997;1241-1257.
123. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem. 254:1979;9627-9632.
124. Spector A., Huang R.R., Yan G.Z., Wang R.R. Thioredoxin fragment 31-36 is reduced by dihydrolipoamide and reduces oxidized protein. Biochem Biophys Res Commun. 150:1988;156-162.
125. Packer L., Roy S., Sen C.K. α-Lipoic acid A metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol. 38:1997;79-101.
126. Nakamura H., De Rosa S., Roederer M., Anderson M.T., Dubs J.G., Yodoi J., Holmgren A., Herzenberg L.A., Herzenberg L.A. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol. 8:1996;603-611.
127. Okamoto T., Sakurada S., Yang J-P, Merin J.P. Regulation of NF-κB and disease control Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr Top Cell Regul. 35:1997;149-161.
128. Sen C.K., Roy S., Packer L. Therapeutic potential of the antioxidant and redox properties of alpha-lipoic acid. Montagnier L., Olivier R., Pasquier C. Oxidative Stress Cancer, AIDS and Neurodegenerative Diseases. 1997;251-267 Marcel Dekker, New York.
129. Sasada T., Iwata S., Sato N., Kitaoka Y., Hirota K., Nakamura K., Nishiyama A., Taniguchi Y., Takabayashi A., Yodoi J. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP) Protective effect of human thioredoxin against CDDP-induced cytotoxicity . J Clin Invest. 97:1996;2268-2276.
130. Wang J., Kobayashi M., Sakurada K., Imamura M., Moriuchi T., Hosokawa M. Possible roles of an adult T-cell leukemia (ATL)-derived factor/thioredoxin in the drug resistance of ATL to adriamycin. Blood. 89:1997;2480-2487.
131. Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., Okamoto T., Yodoi J., Kuwano M., Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55:1995;4293-4296.
132. Gallegos A., Gasdaska J.R., Taylor C.W., Paine-Murrieta G.D., Goodman D., Gasdaska P.Y., Berggren M., Briehl M.M., Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56:1996;5765-5770.
133. Lippoldt A., Padilla C.A., Gerst H., Andbjer B., Richter E., Holmgren A., Fuxe K. Localization of thioredoxin in the rat brain and functional implications. J Neurosci. 15:1995;6747-6756.
134. Ichimiya S., Davis J.G., O'Rourke D.M., Katsumata M., Greene M.I. Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 16:1997;311-321.